Anti-hyperglycemic effects of saffron and its active constituents, crocin and safranal, in alloxan-induced diabetic rats

Journal of Medicinal Plants

Volumn 10, Issue 39, 2011, Pages 82-89

  Kianbakht, S ^a   Hajiaghaee, R ^a  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

Alloxan; Anti hyperglycemic; Crocin; Crocus sativus; Saffron; Safranal

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CROCETIN; CROCIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; METHANOL; SAFFRON; SAFRANAL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROL GROUP; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET RESTRICTION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; KIDNEY FUNCTION; LIVER FUNCTION; MALE; NEPHROTOXICITY; NONHUMAN; RAT;

CROCUS SATIVUS; IRIDACEAE; RATTUS;

EID: 81255167465     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Shane-McWhorter L. Botanical dietary supplements and the treatment of diabetes: What is the evidence? Curr. Diab. Rep. 2005; 5: 391-8. (Pubitemid 41600782)
2. Zareba G, Serradell R, Castaner R, Davies SL, Prous J and Mealy N. Phytotherapies for diabetes. Drugs Future. 2005; 30: 1253-1282.
3. Dey L, Attele AS and Yuan CS. Alternative therapies for type 2 diabetes. Altern. Med. Rev. 2002; 7: 45-58. (Pubitemid 34203979)
4. Gilbert MP and Pratley RE. Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus. Eur. J. Intern. Med. 2009; 20: S309-S318.
5. Maries R and Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine 1995; 2: 137-46.
6. Schmidt M, Betti G and Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien. Med. Wochenschr. 2007; 157: 315-9. (Pubitemid 47356256)
7. Bathaie SZ and Mousavi Z. New applications and mechanisms of action of saffron and its important ingredients. Crit. Rev. Food Sci. Nutr. 2010; 50: 761-86.
8. Liakopoulou-Kyriakides M. and Kyriakidis DA. Crocus sativus biological active constituents. Studies Nat. Prod. Chem. 2002; 26: 293-312.
9. Assimopoulou AN, Sinakos Z and Papageorgiou VP. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother. Res. 2005; 19: 997-1000. (Pubitemid 41820243)
10. Kanakis CD, Tarantilis PA, Tajmir-Riahi HA and Polissiou MG. Crocetin, dimethylcrocetin and safranal bind human serum albumin: stability and antioxidative properties. J. Agric. Food Chem. 2007; 55: 970-7.
11. Chen Y, Zhang H, Tian X, Zhao C, Cai L, Liu Y, Jia L, Yin HX and Chen C. Antioxidant potential of crocins and ethanol extracts of Gardenia jasminoides ELLIS and Crocus sativus L.: A relationship investigation between antioxidant activity and crocin contents. Food Chem. 2008; 109: 484-92.
12. Xi L, Qian Z, Shen X, Wen N and Zhang Y. Crocetin prevents dexamethasone-induced insulin resistance in rats. Planta Medica 2005; 71: 917-22. (Pubitemid 41658567)
13. Xi L, Qian Z, Xu G, Zheng S, Sun S, Wen N, Sheng L, Shi Y and Zhang Y. Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. J. Nutr. Biochem. 2007; 18: 64-72. (Pubitemid 44827721)
14. Xi L, Qian Z, Xu G, Zhou C and Sun S. Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-α and adiponectin expression in rat adipocytes. Br. J. Pharmacol. 2007; 151: 610-7. (Pubitemid 47016298)
15. Sheng L, Qian Z, Shi Y, Yang L, Xi L, Zhao B, Xu X and Ji H. Crocetin improves the insulin resistance induced by high-fat diet in rats. Br. J. Pharmacol. 2008; 154: 1016-24. (Pubitemid 351915062)
16. Xiang M, Qian ZY, Zhou CH, Liu J and Li WN. Crocetin inhibits leukocyte adherence to vascular endothelial cells induced by AGEs. J. Ethnopharmacol. 2006; 107: 25-31. (Pubitemid 44038808)
17. Xiang M, Yang M, Zhou C, Liu J, Li W and Qian Z. Crocetin prevents AGEs-induced vascular endothelial cell apoptosis. Pharmacol. Res. 2006; 54: 268-74. (Pubitemid 44233329)
18. Rahimi R, Nikfar S, Larijani B and Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmacother 2005; 59: 365-73. (Pubitemid 41219650)
19. Evans JL. Antioxidants: do they have a role in the treatment of insulin resistance? Indian J. Med. Res. 2007; 125: 355-72. (Pubitemid 46805452)
20. McCune LM and Johns T. Antioxidant activity relates to plant part, life form and growing condition in some diabetes remedies. J Ethnopharmcol. 2007; 112: 461-9. (Pubitemid 47016879)
21. Rolo AP and Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol. Appl. Pharmacol. 2006; 212: 167-78.
22. Parmar NS and Prakash S. Screening methods in pharmacology. Alpha Science International Ltd. India. 2006, p: 290.
23. Mohajeri D, Mousavi G and Doustar Y. Antihyperglycemic and pancrease-protective effects of Crocus sativus L. (saffron) stigma ethanolic extract on rats with alloxan-induced diabetes. J. Biol. Sci. 2009; 9: 302-10.
24. Arasteh A, Aliyev A, Khamnei S, Delazar A, Mesgari M and Mehmannavaz Y. Effects of hydromethanolic extract of saffron (Crocus sativus) on serum glucose, insulin and cholesterol levels in healthy male rats. J. Med. Plants Res. 2010; 4: 397-402.
25. ISO, 2003. Saffron (Crocus sativus Linnaeus) Part 1: Specifications, and Part 2: Test Methods. International Standards Organisation, Geneva, Switzerland, ISO 3632-1/2.
26. 1c: how do we measure it and what does it mean? Curr. Opin. Endocrinol. Diabetes Obes. 2009; 16: 113-8.